SNCA and Parkinson disease: For instance, miRNA-7 (miR-7) is capable of targeting SNCA, the gene encoding α-synuclein (α-syn), in order to reduce α-syn expression and, as a consequence, to alleviate the neurological damage associated with Parkinson’s Disease (PD) (Hallacli et al., 2022).